➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: June 17, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020576

Email this page to a colleague

« Back to Dashboard

NDA 020576 describes CYSTADANE, which is a drug marketed by Orphan Europe and is included in one NDA. It is available from one supplier. Additional details are available on the CYSTADANE profile page.

The generic ingredient in CYSTADANE is betaine. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the betaine profile page.
Summary for 020576
Applicant:Orphan Europe
Formulation / Manufacturing:see details
Pharmacology for NDA: 020576
Mechanism of ActionMethylating Activity
Suppliers and Packaging for NDA: 020576
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYSTADANE betaine FOR SOLUTION;ORAL 020576 NDA Recordati Rare Diseases 52276-400 52276-400-01 180 g in 1 BOTTLE (52276-400-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrength1GM/SCOOPFUL
Approval Date:Oct 25, 1996TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.